The effects of antilymphocyte serum on the traffic of cells through the popliteal lymph node and on the antibody-forming cells produced within the node.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000187:drug effects*; D000942:Antigens, Bacterial; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000494:pharmacology*; D001798:Blood Proteins / Q000276:immunology; D002465:Cell Movement / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003601:Cytotoxicity Tests, Immunologic; D004710:Endolymph; D005260:Female; D006462:Hemolytic Plaque Technique; D007111:Immunity, Cellular / Q000187:drug effects; D007263:Infusions, Parenteral; D007279:Injections, Subcutaneous; D007958:Leukocyte Count; D008196:Lymph / Q000276:immunology; D008198:Lymph Nodes / Q000187:drug effects* / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008231:Lymphopenia / Q000139:chemically induced; D008854:Microscopy, Electron; D009504:Neutrophils / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D012475:Salmonella / Q000276:immunology; D012756:Sheep; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000942:Antigens, Bacterial; D000961:Antilymphocyte Serum; D001798:Blood Proteins; D014316:Tritium; D013936:Thymidine